3rdPartyFeeds

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TUFN, CRON and GOSS

NEW YORK, NY / ACCESSWIRE / April 13, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate ... Read More...

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="NEW YORK, NY / ACCESSWIRE / April 13, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.” data-reactid=”12″>NEW YORK, NY / ACCESSWIRE / April 13, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Tufin Software Technologies Ltd. (TUFN)
Class Period: securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Tufin’s April 2019 initial public offering
Lead Plaintiff Deadline: June 5, 2020″ data-reactid=”13″>Tufin Software Technologies Ltd. (TUFN)
Class Period: securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Tufin’s April 2019 initial public offering
Lead Plaintiff Deadline: June 5, 2020

The TUFN lawsuit alleges that Tufin Software Technologies Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) Tufin’s customer relationships and growth metrics were overstated, particularly with respect to North America; (2) Tufin’s business was deteriorating, primarily in North America; (3) as a result, Tufin’s representations regarding its sustainable financial prospects were overly optimistic; and (4) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Learn about your recoverable losses in TUFN: http://www.kleinstocklaw.com/pslra-1/tufin-software-technologies-ltd-loss-submission-form?id=6015&amp;from=1” data-reactid=”15″>Learn about your recoverable losses in TUFN: http://www.kleinstocklaw.com/pslra-1/tufin-software-technologies-ltd-loss-submission-form?id=6015&from=1

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Cronos Group Inc. (CRON)
Class Period: May 9, 2019 to March 2, 2020
Lead Plaintiff Deadline: May 11, 2020″ data-reactid=”16″>Cronos Group Inc. (CRON)
Class Period: May 9, 2019 to March 2, 2020
Lead Plaintiff Deadline: May 11, 2020

The complaint alleges Cronos Group Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Cronos had engaged in significant transactions for which its revenue recognition was inappropriate; (ii) the foregoing would foreseeably necessitate reviews that would delay the Company’s ability to timely file its periodic reports; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Learn about your recoverable losses in CRON: http://www.kleinstocklaw.com/pslra-1/cronos-group-inc-loss-submission-form-2?id=6015&amp;from=1” data-reactid=”18″>Learn about your recoverable losses in CRON: http://www.kleinstocklaw.com/pslra-1/cronos-group-inc-loss-submission-form-2?id=6015&from=1

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Gossamer Bio, Inc. (GOSS)
Class Period: common stock between February 8, 2019 and December 13, 2019 and/or who acquired Gossamer shares pursuant or traceable to Gossamer’s documents issued in connection with its February 8, 2019 initial public offering.
Lead Plaintiff Deadline: June 2, 2020″ data-reactid=”19″>Gossamer Bio, Inc. (GOSS)
Class Period: common stock between February 8, 2019 and December 13, 2019 and/or who acquired Gossamer shares pursuant or traceable to Gossamer’s documents issued in connection with its February 8, 2019 initial public offering.
Lead Plaintiff Deadline: June 2, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose: (1) the reasons for Gossamer’s GB001 trial failures; (2) the purported clinical validation of Novartis’ oral DP2 antagonist; and (3) that, as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Learn about your recoverable losses in GOSS: http://www.kleinstocklaw.com/pslra-1/gossamer-bio-inc-loss-submission-form?id=6015&amp;from=1” data-reactid=”21″>Learn about your recoverable losses in GOSS: http://www.kleinstocklaw.com/pslra-1/gossamer-bio-inc-loss-submission-form?id=6015&from=1

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="CONTACT:” data-reactid=”24″>CONTACT:

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com” data-reactid=”25″>J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SOURCE: The Klein Law Firm” data-reactid=”26″>SOURCE: The Klein Law Firm

View source version on accesswire.com:
https://www.accesswire.com/584874/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-TUFN-CRON-and-GOSS

Read More

Add Comment

Click here to post a comment